Doctors Note Logo

Published on: 9/13/2026

Can Jardiance cause dangerous ketoacidosis even if my blood sugar is normal?

Yes, Jardiance (empagliflozin) can cause diabetic ketoacidosis even when glucose readings look normal or only slightly high, a dangerous situation known as euglycemic DKA that is easy to miss because the usual sugar spike never appears. Watch for nausea, vomiting, stomach pain, rapid or labored breathing, unusual fatigue, confusion, or fruity-smelling breath, and know that risk climbs during illness, fasting, very low carbohydrate diets, dehydration, alcohol use, or around surgery. Several details below explain who is most vulnerable, what to do if you suspect ketones, and when this becomes a medical emergency, so read the complete answer before deciding your next step.

Because these symptoms overlap with the flu, food poisoning, and simple exhaustion, guessing wastes time you may not have, and untreated ketoacidosis can become life threatening within hours. Take a free, instant, online symptom check to see how your specific symptoms line up, understand how urgent they may be, and walk into your next conversation with a clinician prepared and informed.

Last reviewed for medical accuracy: 09/13/2026

answer background

Explanation

Jardiance (empagliflozin) is a widely prescribed SGLT2 inhibitor for type 2 diabetes. While it helps lower blood sugar by causing the kidneys to excrete glucose, it carries a rare but serious risk: euglycemic diabetic ketoacidosis (euDKA). Unlike classic DKA, blood sugar may stay near normal. Here’s what you need to know about “jardiance side effects” and how to stay safe.

What Is Euglycemic DKA and Why Does It Happen?

Euglycemic DKA is diabetic ketoacidosis that occurs with blood glucose typically below 250 mg/dL. SGLT2 inhibitors like Jardiance can trigger euDKA by:

  • Reducing circulating glucose, so insulin doses or natural insulin fall.
  • Shifting the body toward fat-burning and ketone production.
  • Masking high ketone levels because blood sugar isn’t extremely elevated.

Even if your blood sugar readings stay in target range, ketones (acidic by-products) can build up, causing dangerous metabolic acidosis.

How Common Is This Side Effect?

According to the FDA and clinical trial data:

  • Jardiance and other SGLT2 inhibitors have a low absolute risk of euDKA—estimated at less than 0.1% per year.
  • Most cases occur in people with type 1 diabetes, off-label use, very low–carb diets or other risk factors (see below).
  • Still, anyone on Jardiance should be aware, because delayed treatment of DKA can be life-threatening.

Recognizing “Jardiance Side Effects” Beyond DKA

While euglycemic DKA is the most serious, Jardiance can cause other side effects. Knowing these helps you decide when to seek help:

Common (1–10%):

  • Urinary tract infections (UTIs) and genital yeast infections
  • Increased urination, dehydration
  • Thirst, dry mouth

Less common but serious (<1%):

  • Low blood pressure (lightheadedness, dizziness)
  • Kidney injury or acute renal failure
  • Serious hypersensitivity reactions (rash, swelling, difficulty breathing)
  • Ketoacidosis (classic or euglycemic)

Who’s at Higher Risk for EuDKA on Jardiance?

You may be more vulnerable if you have:

  • Type 1 diabetes or very low insulin reserves
  • A very low–carbohydrate (keto) diet
  • Recent surgery, trauma or serious illness (infection, heart attack)
  • Alcohol abuse or prolonged fasting
  • Pancreatic disorders (pancreatitis)
  • Dehydration or low fluid intake

Warning Signs of Euglycemic DKA

Because blood sugar can look normal, watch for these red flags:

• Gastrointestinal symptoms

  • Nausea, vomiting, abdominal pain
  • Loss of appetite

• Respiratory changes

  • Rapid, deep breathing (“Kussmaul” respirations)
  • Breath that smells fruity or like nail polish remover

• General symptoms

  • Confusion, difficulty concentrating
  • Extreme fatigue, weakness
  • Thirst, frequent urination

• Laboratory signs (if testing at home or in clinic)

  • Blood ketones (β-hydroxybutyrate) >0.6 mmol/L
  • Urine ketones moderate to large

What To Do If You Suspect EuDKA

  1. Check ketones right away.

    • Home ketone meters or strips can give quick results.
  2. Hold Jardiance.

    • Temporarily stop the medication if ketones are high or you have concerning symptoms.
  3. Hydrate and take simple carbs.

    • Drink water or sugar-containing fluids (juice, sports drinks) to reduce ketone production.
  4. Seek medical attention promptly.

    • EuDKA can progress rapidly. Even with normal blood sugar, you may need IV fluids, electrolytes and insulin under supervision.
  5. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to clarify your next steps.

Prevention Strategies

• Maintain adequate carbohydrate intake
– Don’t follow extreme low-carb diets without medical supervision.

• Stay well-hydrated
– Aim for 1.5–2 L of fluids daily unless otherwise directed.

• Monitor ketones during illness or surgery
– Check more often when you’re unwell, fasting or after major procedures.

• Adjust insulin doses carefully
– Work with your doctor before reducing insulin if your blood sugar is well controlled.

• Know when to pause Jardiance
– Before surgery, during serious illness or if you can’t eat/drink normally.

Balancing Benefits and Risks

Jardiance offers proven advantages beyond blood sugar control:

  • Reduced risk of heart failure hospitalization
  • Slowed progression of kidney disease

Yet awareness of “jardiance side effects”—especially euDKA—is key. Your healthcare team can help you weigh benefits against risks based on your health profile.

When to Talk to Your Doctor

Always seek professional advice if you experience:

  • Persistent nausea, vomiting or abdominal pain
  • Rapid breathing or confusion
  • High ketone readings at home
  • Signs of dehydration or low blood pressure

Any of these could signal a life-threatening emergency. If you’re unsure, a quick conversation can save lives.

Final Thoughts

While euDKA is rare, it’s serious—and can happen even with normal blood sugar levels. Staying informed, checking ketones, and knowing when to pause Jardiance are the best defenses. If anything feels off, don’t hesitate: consider a free, online symptom check, using the doctor approved Ubie Symptom Checker and speak to a doctor about any life-threatening or concerning issues.

Your safety is paramount. Early recognition and prompt treatment of ketoacidosis can prevent complications and keep you on track with your diabetes care plan.

(References)

  • * Modi A, Agrawal A, Morgan F. Euglycemic Diabetic Ketoacidosis: A Review. Curr Diabetes Rev. 2017;13(3):315-321. doi: 10.2174/1573399812666160421121307. PMID: 27097605.

  • * Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am. 2017 May;101(3):587-606. doi: 10.1016/j.mcna.2016.12.011. PMID: 28372715; PMCID: PMC6535398.

  • * Rieg T, Vallon V. Development of SGLT1 and SGLT2 inhibitors. Diabetologia. 2018 Oct;61(10):2079-2086. doi: 10.1007/s00125-018-4654-7. Epub 2018 Aug 22. PMID: 30132033; PMCID: PMC6124499.

  • * Long B, Lentz S, Koyfman A, Gottlieb M. Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management. Am J Emerg Med. 2021 Jun;44:157-160. doi: 10.1016/j.ajem.2021.02.015. Epub 2021 Feb 16. PMID: 33626481.

  • * Dhatariya KK, Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med. 2022 Jun;39(6):e14788. doi: 10.1111/dme.14788. Epub 2022 Feb 27. PMID: 35224769.

  • * Barski L, Golbets E, Jotkowitz A, Schwarzfuchs D. Management of diabetic ketoacidosis. Eur J Intern Med. 2023 Nov;117:38-44. doi: 10.1016/j.ejim.2023.07.005. Epub 2023 Jul 5. PMID: 37419787.

  • * Chow E, Clement S, Garg R. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Res Care. 2023 Oct;11(5). doi: 10.1136/bmjdrc-2023-003666. PMID: 37797963; PMCID: PMC10551972.

  • * Aldafas R, Crabtree T, Alkharaiji M, Vinogradova Y, Idris I. Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis. Age Ageing. 2024 Jan 2;53(1). doi: 10.1093/ageing/afad254. PMID: 38287703; PMCID: PMC10825241.

  • * Cook AK, Behrend E. SGLT2 inhibitor use in the management of feline diabetes mellitus. J Vet Pharmacol Ther. 2025 Jan;48 Suppl 1(Suppl 1):19-30. doi: 10.1111/jvp.13466. Epub 2024 Jul 2. PMID: 38954371; PMCID: PMC11736986.

  • * Veauthier B, Levy-Grau B. Diabetic Ketoacidosis: Evaluation and Treatment. Am Fam Physician. 2024 Nov;110(5):476-486. PMID: 39556629.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.